Delayed conversion to full donor chimerism of skin Langerhans cells compared with blood monocytes
Patient . | Langerhans cells (d) . | Monocytes (d) . |
---|---|---|
8 | R (23); M (81) | D (30, 90, 120) |
9 | M (41); D (120) | D (30, 90, 120) |
11 | R (26); M (103) | D (30, 90) |
10 | M (85) | D (30, 90, 120) |
12 | M (19) | D (30, 90) |
13 | M (25) | D (30) |
15 | M (96) | D (30, 60) |
22 | M (21) | ND |
23 | M (22) | ND |
19 | D (17) | ND |
4 | D (119) | D (30, 90, 120) |
3 | D (145) | D (30, 90, 120) |
5 | D (175) | D (30, 90, 120) |
Patient . | Langerhans cells (d) . | Monocytes (d) . |
---|---|---|
8 | R (23); M (81) | D (30, 90, 120) |
9 | M (41); D (120) | D (30, 90, 120) |
11 | R (26); M (103) | D (30, 90) |
10 | M (85) | D (30, 90, 120) |
12 | M (19) | D (30, 90) |
13 | M (25) | D (30) |
15 | M (96) | D (30, 60) |
22 | M (21) | ND |
23 | M (22) | ND |
19 | D (17) | ND |
4 | D (119) | D (30, 90, 120) |
3 | D (145) | D (30, 90, 120) |
5 | D (175) | D (30, 90, 120) |
Donor-recipient chimerism results of Langerhans cells and CD14-selected monocytes isolated at indicated days (d) after SCT. R indicates > 95% recipient; D, > 95% donor; M, mixed chimerism; and ND, not done.